BioXcel Therapeutics Holds Special Meeting, Approves Reverse Stock Split Plan

On January 28, 2025, BioXcel Therapeutics, Inc. conducted a special meeting of stockholders to decide on crucial matters. The meeting saw the participation of 30,360,492 shares of common stock, either in person or represented by proxy, amounting to approximately 61.17% of the company’s outstanding common stock as of the December 17, 2024 record date. The […]

Leave a Reply

Your email address will not be published.

Previous post Toro Corp. (NASDAQ:TORO) Short Interest Down 28.9% in January
Next post Signing Day Sports (NYSEAMERICAN: SGN) Announces New Sponsorship Agreement with U.S. Army Bowl